Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 27, Number 7—July 2021
CME ACTIVITY - Research

Non–C. difficile Clostridioides Bacteremia in Intensive Care Patients, France

Guillaume MorelComments to Author , Guillaume Mulier, Etienne Ghrenassia, Moustafa Abdel Nabey, Yacine Tandjaoui, Achille Kouatchet, Laura Platon, Frédéric Pène, Anne-Sophie Moreau, Amelie Seguin, Damien Contou, Romain Sonneville, David Rousset, Muriel Picard, Guillaume Dumas, Djamel Mokart, Bruno Megarbane, Guillaume Voiriot, Isabelle Oddou, Elie Azoulay, Lucie Biard, and Lara Zafrani
Author affiliations: Hautepierre Hospital—University Medical Center, Strasbourg, France (G. Morel); Hospital Saint Louis, APHP, Paris, France (G. Morel, G. Mulier, E. Ghrenassia, M.A. Nabey, E. Azoulay, L. Biard, L. Zafrani); Hospital Avicenne, Bobigny, France (Y. Tandjaoui); Teaching Hospital, Angers, France (A. Kouatchet); Lapeyronie University Hospital, Montpellier, France (L. Platon); Hospital Cochin, APHP, Paris (F. Pène); Salengro Hospital, Lille, France (A.-S. Moreau); University Hospital, Nantes, France (A. Seguin); Victor Dupouy Hospital, Argenteuil, France (D. Contou); Hospital Bichat, APHP, Paris (R. Sonneville); University Teaching Hospital, Toulouse, France (D. Rousset),; Institut Universitaire du Cancer—Oncopole, Toulouse (M. Picard); Hospital Saint Antoine, APHP, Paris (G. Dumas); Paoli-Calmettes Institute, Marseille, France (D. Mokart); Hospital Lariboisiere, APHP, Paris (B. Megarbane); Hospital Tenon, APHP, Paris (G. Voiriot); University Medical Center, Strasbourg (I. Oddou); INSERM U976, Paris (L. Zafrani)

Main Article

Table 1

Global characteristics of patients with Clotristridium bacteremia, France*

Characteristic Baseline population, n = 135 Survived, n -= 65
 Died in ICU, n = 70
Age
Age at diagnosis, median (IQR) 64 (51–75) 62 (50–70) 66 (54–79)
Age at diagnostic >65 y
 67 (50)
 27 (42)
 40 (57)
Sex
M 81 (60) 43 (66) 38 (54)
F
 54 (40)
 22 (33)
 32 (46)
All underlying conditions 130 (96) 62 (95) 68 (97)
Diabetes mellitus 34 (26) 19 (31) 15 (22)
Neoplasm 34 (26) 17 (27) 17 (25)
Chronic obstructive pulmonary disease 33 (25) 15 (24) 18 (26)
Alcoholism 26 (20) 11 (18) 15 (22)
Heart failure 26 (20) 9 (15) 17 (25)
Hematological malignancy 19 (15) 7 (11) 12 (18)
Liver cirrhosis 13 (10) 4 (6) 9 (13)
Chronic renal failure 10 (8) 8 (13) 2 (3)
Arteriopathy 9 (7) 3 (5) 6 (9)
Autoimmune diseases 7 (5) 4 (6) 3 (4)
HIV
 1 (1)
 0
 1 (1)
Other predisposing conditions
Surgery or trauma in the previous 15 d 13 (10) 10 (16) 3 (4)
Digestive surgery 10 (77) 7 (70) 3 (100)
Trauma
 3 (23)
 3 (30)
 0
Immunosuppressive agents
Patients receiving Immunosuppressive agents 38 (28) 18 (28) 20 (29)
Steroids 20 (53) 9 (50) 11 (55)
Chemotherapy 20 (53) 9 (50) 11 (55)
Immunosuppressive drugs 10 (26) 6 (33)
 4 (20)

*Data are no. (%) unless otherwise indicated.

Main Article

Page created: May 27, 2021
Page updated: June 18, 2021
Page reviewed: June 18, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external